Current Opinion in Obstetrics & Gynecology

Papers
(The TQCC of Current Opinion in Obstetrics & Gynecology is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Pharmacologic therapeutic options for sexual dysfunction43
Editorial introductions36
Syphilis screening in pregnancy: no time for complacency31
A review of ethnic disparities in preeclampsia26
Treatment options for molecular subtypes of endometrial cancer in 202326
Optimizing postpartum contraception for high-risk obstetric patients26
Perioperative visits in minimally invasive gynecologic surgery25
Editorial introductions25
Gynecologic counseling for patients undergoing bariatric surgery: a scoping review22
Recurrent pregnancy loss: unexplained or misunderstood?21
Review of chatbots in urogynecology20
Perioperative hormone treatment of endometriosis17
Pelvic abscess – to drain or not to drain?16
Progestin-primed ovarian stimulation16
Novel nonhormonal treatments for vasomotor symptoms of menopause16
Menopause, weight, and metabolic health – considerations for a patient centered, multidisciplinary approach16
Fetal growth disorders in twin gestations16
A review of racial disparities in ovarian cancer and clinical trials15
Applications of vaginal natural orifice transluminal endoscopic surgery (vNOTES) in gynecologic surgery15
Sentinel lymphatic mapping for gynecologic malignancies15
Does PGT-A affect cumulative live birth rate?14
Editorial introductions14
Effectiveness of ultrasound for endometriosis diagnosis14
Pharmacotherapy for opioid use disorder in pregnancy13
Radiofrequency ablation methods for uterine sparing fibroid treatment13
The minimally invasive approach to abdominal cerclage: indications, complications, and techniques for placement13
Providing adolescent-friendly sexually transmitted infection screening and treatment services13
Fertility counseling for patients with hereditary breast and ovarian cancer syndrome12
Role of sentinel node mapping in endometrial cancer in 202512
Social and clinical science discovery in family planning: the data keep coming12
Adolescent reproductive health in a post-Dobbs landscape: a review12
Assisted reproductive technology for patients with medical comorbidities11
Violence in the healthcare workplace11
Rho(D) immune globulin shortage and fetal Rh(D) screening with cell-free DNA10
The surgical gender gap: the impact of surgeon gender in medicine and gynecologic surgery10
A review of menopause in transgender and gender diverse individuals10
Alternative treatments of adenomyosis – an update in procedural management and clinical outcomes9
Impact of fibroids on fertility, pregnancy loss, and preconception management9
Trastuzumab deruxtecan and the evolving role of human epidermal growth factor receptor 2–targeted antibody–drug conjugates in breast and ovarian cancer9
Patient navigation in reproductive healthcare9
Frozen embryo transfers in a natural cycle: how to do it right9
Aftercare following second trimester abortion procedures9
Editorial introductions9
Editorial introductions9
Current opinions: updates on the changing landscape in the management of cervical cancer9
Not all platelet-rich plasma are created equal9
The impact of air pollution and endocrine disruptors on reproduction and assisted reproduction8
Routine screening for gestational diabetes: a review8
Late bloomers: exploring the reproductive potential of day 7 embryos8
Review of sustainable practices for the gynecology operating room8
An update on the current indications for in vitro maturation8
Thoracic and diaphragmatic endometriosis: an overview of diagnosis and surgical treatment8
Maximizing progress through minimally invasive incisions: the role of minimally invasive surgery in global gynecology8
Endometrial cancer therapy in 20268
Gene editing using CRISPR-Cas9 technology: potential implications in assisted reproduction8
Impact of the injectable weight-loss medications, glucagon-like peptide-1 receptor agonists, on reproductive health in non-polycystic ovary syndrome state8
New treatment options for nonsurgical management of uterine fibroids8
Contemporary uses of “lethal” or “life limiting” terminology in perinatal research8
Pap smear recommendations in older women, does the data support stopping?7
Mobile programs in family planning7
Minimally invasive and ablative therapies for symptomatic uterine fibroids: a narrative review7
Beyond the cuff: a consideration of factors that affect sexual function after benign hysterectomy7
Editorial introductions7
Opportunistic salpingectomy for prevention of ovarian cancer among the general population7
The new age of periviability7
Editorial introductions7
Activity restriction after minimally invasive gynecologic surgery7
Treatment options for endometrial hypoproliferation7
Racial disparities in early pregnancy: a narrative review6
Mental health conditions and contraception: current landscape, reproductive health and obstetric outcomes, and clinical guidance6
Menopause, cognition, and Alzheimer’s disease risk6
The use of GLP-1: receptor agonist medications for benign gynecology6
Evolving best practices in the surgical management of endometriosis – examining the evidence and expert opinion6
Take it or leave it: oophorectomy at the time of benign hysterectomy6
#Birth control: contraception conversations on social media6
Clinical utility of mosaic and segmental aneuploid embryos in assisted reproduction6
Is there a role for radiofrequency and assisted reproductive technology?6
Editorial introductions6
Unravelling the vaginal microbiome, impact on health and disease6
Chronic endometritis, chronic questions: a narrative review of current practices6
The aging brain: risk factors and interventions for long term brain health in women6
Clinical strategies for management of abnormal uterine bleeding: hormonal and nonhormonal interventions in women at risk for venous thromboembolism6
1.4546890258789